- Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells(2020)
Auteurs: Koen Vermeulen, Guy Bormans
- Design and Challenges of Radiopharmaceuticals(2019)
Auteurs: Koen Vermeulen, Mathilde Vandamme, Guy Bormans, Frederik Cleeren
Pagina's: 339 - 356
- Evaluation of [11C]KB631 as a PET tracer for in vivo visualisation of HDAC6 in B16.F10 melanoma☆(2019)
Auteurs: Koen Vermeulen, Kaat Luyten, Guy Bormans
Pagina's: 1 - 11
- Evaluation of [11C]NMS-E973 as a PET tracer for in vivo visualisation of HSP90(2019)
Auteurs: Koen Vermeulen, Evelyne Naus, Kaat Luyten, Sofie Celen, Joost Schymkowitz, Frederic Rousseau, Guy Bormans
Pagina's: 554 - 572
